Journal Guides6 min readUpdated Apr 2, 2026

Is Molecular Cell a Good Journal? Impact, Scope, and Fit

Molecular Cell (IF 16.6, Cell Press) is the Cell family's mechanism-focused sibling. Here is who should submit and how it compares to Cell, Nature Cell Biology, and EMBO Journal.

Research Scientist, Neuroscience & Cell Biology

Author context

Works across neuroscience and cell biology, with direct expertise in preparing manuscripts for PNAS, Nature Neuroscience, Neuron, eLife, and Nature Communications.

Journal fit

See whether this paper looks realistic for Molecular Cell.

Run the Free Readiness Scan with Molecular Cell as your target journal and see whether this paper looks like a realistic submission.

Check my manuscript fitAnthropic Privacy Partner. Zero-retention manuscript processing.See sample reportOr compare against 1000+ journals and conferences
Journal context

Molecular Cell at a glance

Key metrics to place the journal before deciding whether it fits your manuscript and career goals.

Full journal profile
Impact factor16.6Clarivate JCR
Acceptance rate~13%Overall selectivity
Time to decision3-5 dayDesk: 3-5 days
Open access APC$10,400 USDGold OA option

What makes this journal worth targeting

  • IF 16.6 puts Molecular Cell in a visible tier — citations from papers here carry real weight.
  • Scope specificity matters more than impact factor for most manuscript decisions.
  • Acceptance rate of ~~13% means fit determines most outcomes.

When to look elsewhere

  • When your paper sits at the edge of the journal's stated scope — borderline fit rarely improves after submission.
  • If timeline matters: Molecular Cell takes ~3-5 day. A faster-turnaround journal may suit a grant or job deadline better.
  • If OA is required: gold OA costs $10,400 USD. Check institutional agreements before submitting.
Quick verdict

How to read Molecular Cell as a target

This page should help you decide whether Molecular Cell belongs on the shortlist, not just whether it sounds impressive.

Question
Quick read
Best for
Molecular Cell publishes research that provides new mechanistic insights into core cellular processes at the.
Editors prioritize
Mechanistic insight at the molecular level
Think twice if
Confirming known mechanisms without adding new insight
Typical article types
Article, Short Article, Resource

Molecular Cell (IF 16.6, Cell Press, Q1 Molecular Biology and Cell Biology) is the Cell family's mechanism-focused journal. It publishes papers that explain how molecular processes work - with the emphasis on "how," not just "what."

The positioning within Cell Press is specific: papers that are too specialized for Cell (IF 42.5) but too mechanistically complete and too strong for Cell Reports (IF 6.9) land at Molecular Cell. It is not a step down from Cell. It is the right home for deep molecular mechanism papers that speak to the molecular biology community rather than all of biology.

Molecular Cell at a Glance

Metric
Detail
Impact Factor (2024)
16.6
Publisher
Cell Press (Elsevier)
Quartile
Q1 (Molecular Biology; Cell Biology)
Acceptance Rate
~5-8%
Format
Articles, Short Articles, Resources
Open Access APC
N/A (subscription; OA option available)
Review Speed
6-10 weeks typical
Key Strength
Mechanistically complete molecular biology

How Molecular Cell Compares to Peer Journals

Feature
Molecular Cell
Cell
Nature Cell Biology
EMBO Journal
IF (2024)
16.6
42.5
20.7
9.5
Acceptance Rate
~5-8%
~5%
~8-10%
~10-15%
Scope
Molecular mechanisms
All biology
Broad cell biology
Molecular and cell biology
What It Wants
How molecular processes work
Field-defining discoveries
Cell biology mechanism
Mechanistic biology (broader)
Publisher
Cell Press
Cell Press
Springer Nature
EMBO / Springer Nature

Nature Cell Biology (IF 19.1) has a higher IF but broader scope - it takes cell biology broadly, not just molecular mechanism. EMBO Journal (IF 9.5) publishes similar mechanistic work but is less selective. Genes & Development (IF ~7.7) is another comparator for gene regulation mechanisms but sits a tier below in selectivity.

The practical decision for most authors is between Molecular Cell and EMBO Journal. If the mechanistic package is airtight and the significance extends beyond a narrow specialist audience, Molecular Cell is the stronger target. If the mechanism is solid but still has one visible gap, or the audience is quite specialized, EMBO Journal is the more realistic option.

What Molecular Cell Editors Actually Select

Cell Press professional editors with deep molecular biology expertise run the editorial screen. They ask one question with unusual precision: is the mechanism actually solved?

Papers that succeed share these traits:

  1. The central molecular mechanism is explained, not just identified - the paper shows how a process works, not just that it occurs
  2. Multi-angle evidence supports the mechanism - genetics plus biochemistry plus cell biology, or structural plus functional, or equivalent orthogonal approaches
  3. The significance extends beyond the immediate specialist community - nearby molecular biologists would care
  4. The first figure and abstract make the mechanistic advance clear without requiring specialist background

The most common rejection profile is technically excellent molecular biology where the mechanism is still partially inferred. One key experiment is missing, or the evidence supports the mechanism from only one angle. Molecular Cell editors catch this consistently.

Submit If / Think Twice If

Submit if:

  • Your paper explains how a molecular process works with mechanistic completeness - not just that it occurs
  • The mechanism is supported by multiple independent lines of evidence (genetics, biochemistry, structural biology, cell biology)
  • The significance extends beyond your immediate specialist niche - molecular biologists in adjacent areas would engage
  • The story is stable enough that the first three reviewer objections you can predict are already addressed

Think twice if:

  • The paper identifies a new player or regulator but does not fully explain the mechanism - one more set of experiments may close it
  • The evidence comes from only one experimental approach - multi-angle support is expected
  • The audience is highly specialized and the broader molecular biology community would not engage
  • The paper is still primarily phenotype-driven with the mechanism partially inferred - Cell Reports or EMBO Journal may be the more honest current target

Journal fit

See whether this paper looks realistic for Molecular Cell.

Run the scan with Molecular Cell as the target. Get a manuscript-specific fit signal before you commit.

Check my manuscript fitAnthropic Privacy Partner. Zero-retention manuscript processing.See sample reportOr compare against 1000+ journals and conferences

Frequently Asked Questions

Is Molecular Cell a consolation prize for Cell rejection?

No. Many Molecular Cell papers would never have been submitted to Cell because their significance is molecular-mechanism-specific rather than biology-wide. The journals serve different audiences. However, papers transferred from Cell to Molecular Cell after editorial assessment is a real and legitimate pathway.

Should I try Nature Cell Biology instead?

If the paper has broader cell biology significance beyond the molecular mechanism - involving cell behavior, tissue organization, or organismal biology - Nature Cell Biology (IF 19.1) may be the stronger target. If the heart of the paper is the molecular mechanism itself, Molecular Cell is more natural.

What about structural biology papers?

Molecular Cell publishes structural biology when the structure reveals a mechanism with broad molecular biology significance. A structure paper that explains how a molecular machine works is a strong fit. A structure solved for completeness without mechanistic insight belongs in a structural biology journal.

Does Molecular Cell publish chromatin and epigenetics?

Yes - chromatin biology, epigenetic regulation, DNA repair, transcription mechanisms, and RNA biology are core areas. These are some of the journal's most consistent content domains.

Bottom Line

Molecular Cell is the right home for molecular biology papers that solve a mechanism - not just identify players, but explain how they work. The bar is mechanistic completeness, multi-angle evidence, and significance that extends beyond a narrow specialist community. If your paper meets that standard, this is one of the strongest venues in molecular biology. If the mechanism is still partially inferred, close it first or consider EMBO Journal or Cell Reports.

Before submitting, a Molecular Cell scope and readiness check can help you assess whether the mechanistic completeness and evidence depth match what Molecular Cell editors demand.

Before you submit

A Molecular Cell submission readiness check identifies the specific framing and scope issues that trigger desk rejection before you submit.

Frequently asked questions

Yes. Molecular Cell (IF 16.6, Cell Press) is a top-tier molecular biology journal that publishes mechanistically complete research explaining how biology works at the molecular level. It is the Cell family's mechanism-focused sibling - papers that are too specialized for Cell but too strong for Cell Reports find their natural home here.

Approximately 5-8%. Molecular Cell is among the most selective molecular biology journals. Professional Cell Press editors screen for mechanistic completeness, multi-angle evidence, and significance beyond a narrow specialist audience before sending to review.

Cell (IF 42.5) publishes field-defining biology of any type with the broadest possible significance. Molecular Cell (IF 16.6) publishes mechanistically deep molecular biology that may be too specialized for Cell's general readership but represents outstanding molecular mechanism work. Think of Molecular Cell as the right home for excellent mechanism papers that do not need to be the broadest biology story of the year.

Both publish mechanistic molecular biology. Molecular Cell (IF 16.6, Cell Press) is more selective and has the Cell Press editorial infrastructure with professional in-house editors. EMBO Journal (IF 9.5, EMBO/Springer Nature) is slightly less selective and has a broader European molecular biology readership. The editorial bar for mechanistic completeness is comparable, but Molecular Cell is harder to get into.

It means the paper explains how a molecular process works - not just that it occurs. The mechanism is demonstrated through multiple independent lines of evidence (genetics, biochemistry, structural biology, cell biology). A paper that identifies a new regulator is not enough; the paper must explain how that regulator works.

References

Sources

  1. 1. Molecular Cell journal homepage, Cell Press.
  2. 2. Molecular Cell information for authors, Cell Press.
  3. 3. Clarivate Journal Citation Reports (2024 release).

Final step

See whether this paper fits Molecular Cell.

Run the Free Readiness Scan with Molecular Cell as your target journal and get a manuscript-specific fit signal before you commit.

Anthropic Privacy Partner. Zero-retention manuscript processing.

Internal navigation

Where to go next

Check my manuscript fit